Region: Taiwan

Austrian pharma group’s award partially enforced

A US court has partially enforced an ICC award won by an Austrian pharmaceuticals company against its Taiwanese partner after a €142 million order for damages was set aside in Germany.

22 March 2022

Taiwan pharma group quashes damages award in Germany

The German Supreme Court has set aside a €140 million damages award against a Taiwanese pharmaceuticals company after finding the ICC tribunal violated its right to be heard – in a fight over a blood cancer drug that has spawned a second ICC case worth US$5 billion and a criminal complaint.

16 February 2022

Austrian pharma company alleges arbitral fraud

An Austrian pharmaceuticals company has asked a US court to grant discovery to support criminal allegations that its Taiwanese partner has made fraudulent statements in two ICC arbitrations arising from a multibillion-euro dispute over a blood cancer drug.

20 January 2022

Taiwan (ROC) Chinese Arbitration Association, Taipei

Featured in Guide to Regional Arbitration (volume 6 - 2018)

17 January 2018

US court hears challenge to SIAC "gag order"

Japanese electronics company Sharp has asked a US court to block a SIAC emergency arbitrator's confidentiality order prohibiting public discussion of an arbitration with a Chinese licensee - which it says breaches its right to free speech under the US Constitution.

16 August 2017

Samsung and Sharp to clash in New York

The electronic arm of South Korea's Samsung has filed a US$429 million ICC claim against three companies thought to include Japan's Sharp, to be seated in New York.

23 January 2017

Get unlimited access to all Global Arbitration Review content